Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomonori Oura

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Statistics in Medicine|July 18, 2009
Sample sizes for a robust ranking and selection of genes in microarray experimentsShigeyuki Matsui, Tomonori Oura
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 3, 2024
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc AnalysisYukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Diabetes, Obesity & Metabolism|October 5, 2023
Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes: A subgroup analysis of the SURPASS J-mono studyTakeshi Osonoi, Tomonori Oura, Tetsuaki Hirase
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 16, 2023
Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono TrialHitoshi Ishii, Tomonori Oura, Masakazu Takeuchi
Biostatistics (Oxford, England)|July 25, 2009
Sample size calculations for controlling the distribution of false discovery proportion in microarray experimentsTomonori Oura, Shigeyuki Matsui, Koji Kawakami
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 14, 2025
Insulin Sensitivity and Beta-Cell Function Following Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J-mono AnalysisYoshiyuki Hamamoto, Tomonori Oura, Tetsuaki Hirase
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 24, 2019
Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled StudyHitoshi Ishii, Yukiko Onishi, Tomonori Oura, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 22, 2017
Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 DiabetesNoriyuki Iwamoto, Akiko Matsui, Hirotaka Kazama, et al.
Computational and Mathematical Methods in Medicine|May 22, 2013
Cancer outlier analysis based on mixture modeling of gene expression dataKeita Mori, Tomonori Oura, Hisashi Noma, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 30, 2020
Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin RegimenYukiko Onishi, Hitoshi Ishii, Tomonori Oura, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Statistics in Medicine|July 18, 2009
Sample sizes for a robust ranking and selection of genes in microarray experimentsShigeyuki Matsui, Tomonori Oura
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 3, 2024
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc AnalysisYukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Diabetes, Obesity & Metabolism|October 5, 2023
Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes: A subgroup analysis of the SURPASS J-mono studyTakeshi Osonoi, Tomonori Oura, Tetsuaki Hirase
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 16, 2023
Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono TrialHitoshi Ishii, Tomonori Oura, Masakazu Takeuchi
Biostatistics (Oxford, England)|July 25, 2009
Sample size calculations for controlling the distribution of false discovery proportion in microarray experimentsTomonori Oura, Shigeyuki Matsui, Koji Kawakami
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 14, 2025
Insulin Sensitivity and Beta-Cell Function Following Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J-mono AnalysisYoshiyuki Hamamoto, Tomonori Oura, Tetsuaki Hirase
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 24, 2019
Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled StudyHitoshi Ishii, Yukiko Onishi, Tomonori Oura, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 22, 2017
Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 DiabetesNoriyuki Iwamoto, Akiko Matsui, Hirotaka Kazama, et al.
Computational and Mathematical Methods in Medicine|May 22, 2013
Cancer outlier analysis based on mixture modeling of gene expression dataKeita Mori, Tomonori Oura, Hisashi Noma, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 30, 2020
Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin RegimenYukiko Onishi, Hitoshi Ishii, Tomonori Oura, et al.
Pageof 4